These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19056237)

  • 1. Indications and requirements for the use of prerandomization.
    Schellings R; Kessels AG; ter Riet G; Sturmans F; Widdershoven GA; Knottnerus JA
    J Clin Epidemiol; 2009 Apr; 62(4):393-9. PubMed ID: 19056237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pre-randomisation in study designs: getting past the taboo].
    Schellings R; Kessels AG; Sturmans F
    Ned Tijdschr Geneeskd; 2008 Sep; 152(38):2053-6. PubMed ID: 18837179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ethical problems in randomized clinical trials from the aspect of statistics. Part I. Is patient randomization acceptable from the ethical viewpoint?].
    Haas T
    Cas Lek Cesk; 2001 Jun; 140(11):335-42. PubMed ID: 11431853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ['Informed consent' and prerandomization].
    de Craen AJ
    Ned Tijdschr Geneeskd; 2000 Jul; 144(27):1301-3. PubMed ID: 10918907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An argument that all prerandomized clinical trials are unethical.
    Marquis D
    J Med Philos; 1986 Nov; 11(4):367-83. PubMed ID: 3819605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudo cluster randomization dealt with selection bias and contamination in clinical trials.
    Teerenstra S; Melis RJ; Peer PG; Borm GF
    J Clin Epidemiol; 2006 Apr; 59(4):381-6. PubMed ID: 16549260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruitment in Clinical Trials: The Use of Zelen's Prerandomization in Recent Neurovascular Studies.
    Raymond J; Darsaut TE; Roy DJ
    World Neurosurg; 2017 Feb; 98():403-410. PubMed ID: 27876665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A SAS macro for constrained randomization of group-randomized designs.
    Chaudhary MA; Moulton LH
    Comput Methods Programs Biomed; 2006 Sep; 83(3):205-10. PubMed ID: 16870302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of randomized controlled trials on seclusion and mechanical restraint.
    Bergk J; Einsiedler B; Steinert T
    Clin Trials; 2008; 5(4):356-63. PubMed ID: 18697850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study designs for effectiveness and translation research :identifying trade-offs.
    Mercer SL; DeVinney BJ; Fine LJ; Green LW; Dougherty D
    Am J Prev Med; 2007 Aug; 33(2):139-154. PubMed ID: 17673103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Unnecessary delays in ethical approval of multicentre clinical trials].
    Evers JL
    Ned Tijdschr Geneeskd; 2008 Sep; 152(38):2062-4. PubMed ID: 18837181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical and legal issues in emergency research: barriers to conducting prospective randomized trials in an emergency setting.
    Morrison CA; Horwitz IB; Carrick MM
    J Surg Res; 2009 Nov; 157(1):115-22. PubMed ID: 19765724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudo cluster randomization: a treatment allocation method to minimize contamination and selection bias.
    Borm GF; Melis RJ; Teerenstra S; Peer PG
    Stat Med; 2005 Dec; 24(23):3535-47. PubMed ID: 16007575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cluster without fluster: The effect of correlated outcomes on inference in randomized clinical trials.
    Proschan M; Follmann D
    Stat Med; 2008 Mar; 27(6):795-809. PubMed ID: 17594680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing phase III or IV trials for vaccines: choosing between individual or cluster randomised trial designs.
    Vaucher P
    Vaccine; 2009 Mar; 27(13):1928-31. PubMed ID: 19368773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Deferred consent for inclusion of patients unable to give their consent in studies in the field of emergency medicine].
    Kompanje EJ; Jansen TC; Le Noble JL; de Geus HR; Bakker J
    Ned Tijdschr Geneeskd; 2008 Sep; 152(38):2057-61. PubMed ID: 18837180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative efficiency of Zelen's prerandomization design for clinical trials.
    Anbar D
    Biometrics; 1983 Sep; 39(3):711-8. PubMed ID: 6652204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balanced two-stage designs for phase II clinical trials.
    Ye F; Shyr Y
    Clin Trials; 2007; 4(5):514-24. PubMed ID: 17942467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "best balance" allocation led to optimal balance in cluster-controlled trials.
    de Hoop E; Teerenstra S; van Gaal BG; Moerbeek M; Borm GF
    J Clin Epidemiol; 2012 Feb; 65(2):132-7. PubMed ID: 21840173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.